James B. Renacci sold PLDT Inc ADR (NYSE: PHI)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 1 trade in PLDT Inc ADR (PHI) since 2017, a single sale, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: James B. Renacci sold $15,001 - $50,000 of PLDT Inc ADR (NYSE: PHI) on December 15, 2017. Since that trade, PHI is up +17.19% against the S&P 500 up +210.98%, an outperformance of -193.79%.
Data updated
James B. Renacci's PHI trades vs the price
PHI is up +17.19% since James B. Renacci sold on December 15, 2017, versus +210.98% for the S&P 500.
Performance since this trade
All James B. Renacci PHI trades
James B. Renacci & PHI trading FAQ
Is it legal for James B. Renacci to trade PLDT Inc ADR (PHI) stock?
Yes. Members of Congress are allowed to trade individual stocks, including PLDT Inc ADR (PHI), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci sell PHI?
James B. Renacci disclosed a sale of $15,001 - $50,000 of PLDT Inc ADR (PHI) on December 15, 2017, according to public STOCK Act filings.
How has PHI performed since James B. Renacci's trade?
Since James B. Renacci sold PHI on December 15, 2017, the stock is up +17.19%, versus +210.98% for the S&P 500 over the same period, an outperformance of -193.79%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional PHI trades?
Quantellect tracks every disclosed congressional trade in PLDT Inc ADR (PHI) on the PLDT Inc ADR congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's PHI tradesAll congressional filings for PLDT Inc ADRJames B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.